Gastrointest Endosc22 May 2025
A cost-effectiveness analysis involving 4,557 patients found that prophylactic clipping (PC) during endoscopic mucosal resection (EMR) of large non-pedunculated colon polyps is beneficial. For a typical 65-year-old undergoing EMR, PC yielded an incremental cost-effectiveness ratio (ICER) of -$154,706. It proved cost-effective for very large polyps…
Ann Surg Oncol22 May 2025
An analysis of 184 patients with anatomically resectable pancreatic cancer and elevated CA19-9 levels demonstrated that those receiving intensive neoadjuvant chemotherapy (NAC) showed significantly improved overall survival compared to those undergoing upfront surgery, with median survival times of 52.7 months versus 22.7 months (p <…
Surg Endosc22 May 2025
A retrospective study involving 629 patients evaluated rebleeding rates after endoscopic variceal ligation (EVL). Results revealed rebleeding in 34.8% and 80.1% of patients within 6 weeks and 6 months, respectively. Identified factors included esophageal variceal severity and platelet count, both independent risk predictors. Developed visual…
Int J Surg22 May 2025
A deep learning diagnostic system combining CT and ultrasound achieved superior accuracy in detecting hepatic echinococcosis and other liver conditions compared to individual modalities and physician evaluations. The integrated model demonstrated an impressive accuracy of 81.6% in internal tests and 84.9% in external assessments, with…
Intestine and Lower Gastrointestinal Tract22 May 2025
CPLX2 and SNAP25 have been identified as significant players in the progression of colorectal cancer liver metastasis. Researchers discovered that these genes are overexpressed in metastatic tissues compared to primary tumors. They also noted that these genes positively regulate the phosphatidylinositol 3-kinase-AKT signaling pathway. Through…
Lancet21 May 2025
Nivolumab combined with ipilimumab significantly enhances overall survival for patients with untreated unresectable hepatocellular carcinoma compared to lenvatinib or sorafenib. After a median follow-up of 35.2 months, the median overall survival was 23.7 months for nivolumab plus ipilimumab, versus 20.6 months for the other treatments.…
Clin Gastroenterol Hepatol21 May 2025
Salvage endoscopic submucosal dissection (ESD) for previously attempted colorectal lesions demonstrated an en bloc rate of 83.4% and curative resection in 73.5% of cases. Among 415 lesions treated, adverse events occurred in 11.8% of patients, with the most frequent being intraprocedural perforation. Notably, there were…
J Gastroenterol21 May 2025
A novel axon guidance-related microRNA panel (AGMP) has shown exceptional predictive capabilities for local recurrence in pancreatic cancer patients following curative surgery. This model, trained on diverse cohorts, achieved an AUC of 0.95 in the training cohort and maintained high validation scores across three independent…
Eur J Med Res21 May 2025
A robust mortality risk prediction model was developed for geriatric patients over 65 undergoing non-cardiac surgery. Utilizing data from 1960 patients and machine learning techniques, the CatBoost model outperformed traditional risk assessments with an AUC of 0.96 and 0.98 in validation datasets. Key factors influencing…
Intestine and Lower Gastrointestinal Tract21 May 2025
A combined approach of SiLaC® and EPSiT® for pilonidal sinus disease demonstrated promising results in a study involving 83 patients. The mean operative time was 25 minutes, with a low postoperative pain score of 1.2. Most patients (92.3%) returned to normal activities within 24 hours,…